The French government would risk legal action if it broke treaty obligations in its efforts to deter Swiss drug maker Novartis (NOVN.VX: Quote, Profile, Research) from buying French rival Aventis, a European Commission spokesman said on Thursday.
The French government would risk legal action if it broke treaty obligations in its efforts to deter Swiss drug maker Novartis (NOVN.VX: Quote, Profile, Research) from buying French rival Aventis, a European Commission spokesman said on Thursday.
